tiprankstipranks
GRI Bio (GRI)
NASDAQ:GRI
US Market

GRI Bio (GRI) Stock Forecast & Price Target

Compare
175 Followers
See the Price Targets and Ratings of:

GRI Financial Forecast

GRI Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.
No data currently available

GRI Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright
$10
Buy
70.36%
Upside
Initiated
12/09/24
H.C. Wainwright starts GRI Bio, Inc. (GRI) at BuyH.C. Wainwright analyst Matthew Keller initiates coverage on GRI Bio, Inc. (NASDAQ: GRI) with a Buy rating and a price target of $10.00.
Ascendiant
$12$13
Buy
121.47%
Upside
Reiterated
12/04/24
We are adjusting our 2024 estimates for EPS to $(2.62) from $(4.97).
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright
$10
Buy
70.36%
Upside
Initiated
12/09/24
H.C. Wainwright starts GRI Bio, Inc. (GRI) at BuyH.C. Wainwright analyst Matthew Keller initiates coverage on GRI Bio, Inc. (NASDAQ: GRI) with a Buy rating and a price target of $10.00.
Ascendiant
$12$13
Buy
121.47%
Upside
Reiterated
12/04/24
We are adjusting our 2024 estimates for EPS to $(2.62) from $(4.97).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

GRI Analyst Recommendation Trends

Rating
Nov 21
Dec 21
Jan 24
Oct 24
Dec 24
Strong Buy
0
0
0
1
1
Buy
1
2
2
1
2
Hold
0
0
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
2
3
3
4
In the current month, GRI has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. GRI average Analyst price target in the past 3 months is $10.00.
Each month's total comprises the sum of three months' worth of ratings.

GRI Stock Forecast FAQ

What is GRI’s average 12-month price target, according to analysts?
Based on analyst ratings, GRI Bio’s 12-month average price target is $10.00.
    What is GRI’s upside potential, based on the analysts’ average price target?
    GRI Bio has 70.36% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GRI a Buy, Sell or Hold?
          GRI Bio has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is GRI Bio’s price target?
            The average price target for GRI Bio is $10.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $10.00 ,the lowest forecast is $10.00. The average price target represents 70.36% Increase from the current price of $5.87.
              What do analysts say about GRI Bio?
              GRI Bio’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of GRI?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis